The synthesis of d-glucosamine-1-carboxylic acid based β-sugar amino acids (β-SAAs) is typically performed in nine consecutive steps via an inefficient OAc → Br → CN conversion protocol with low overall yield. Here, we present the improved and more efficient synthesis of both Fmoc-GlcAPC-OH and Fmoc-GlcAPC(Ac)-OH, β-SAAs consisting of only 4–5 synthetic steps. Their active ester and amide bond formation with glycine methyl ester (H-Gly-OMe) was completed and monitored by 1H NMR. The stability of the pyranoid OHs protecting the acetyl groups was investigated under three different Fmoc cleavage conditions and was found to be satisfactory even at high piperidine concentration (e.g. 40%). We designed a SPPS protocol using Fmoc-GlcAPC(Ac)-OH to produce model peptides Gly-β-SAA-Gly as well as Gly-β-SAA-β-SAA-Gly with high coupling efficiency. The products were deacetylated using the Zemplén method, which allows the hydrophilicity of a building block and/or chimera to be fine-tuned, even after the polypeptide chain has already been synthesized.
Like polypeptides and proteins, oligosaccharides are evolutionarily fine-tuned polymers composed of a limited number of building blocks, and like polypeptides and proteins, they are involved in most cellular processes (Stern and Jedrzejas 2008; BeMiller 2008; Seeberger 2005; Roseman 2001; Robty 1998; Xiao et al. 2017; Varki 2022). Sugar amino acids (SAAs) (Risseeuw et al. 2013; Tian et al 2015; El Oualid 2004; Lohof et al. 1999, 2000; McDevitt and Lansbury 1996; von Roeden et al 1996; Goldschmidt Gőz et al. 2018; Nagy et al. 2017; Gruner et al. 2002a, b) combine several preferred properties of both amino acids and carbohydrates, and they also offer the possibility of conformational design from β-SAA-based foldamers (Gellman 1998) or chimeric building blocks, allowing the synthesis of stable helical or elongated biocompatible oligomers with predetermined polarity and spatial features. Due to their structural and stereochemical complexity, β-SAAs are versatile and tunable. For example, d-glucose (d-Glc) and d-mannose (d-Man) differ from each other only in the configuration of the C-2 atom, as C-2 epimers, yet they have markedly different conformational properties (Pigman and Horton 1972; Mayes et al. 2014; Rao 1998). Furthermore, structurally different foldamer building units (e.g. d-xylose (d-Xyl) and d-ribose (d-Rib), C-3 epimers (Nagy et al. 2017)) can generate different 3D folds and stabilize different secondary structural elements (Chandrasekhar et al. 2004; Gruner et al. 2002a, b; Menyhárd et al. 2017). While oligomers composed of -RibAFU(ip)- adopt a H12 helical structure, its C-3 epimer, namely the -XylAFU(ip)- building block, forms the broader H14 helix in solution.
SAAs with variable ring size (e.g. furanoid, pyranoid), configurational and conformational properties can be decorated with different functional groups, e.g. -OH, -NH2, -CH2-OH, -OAc, -NHAc, (Risseeuw et al. 2013; Gruner et al. 2002a, b; Tian et al. 2015; Gervay-Hague and Weathers 2002), than natural product SAAs such as sialic acids, neuraminic acid, etc. In line with the recently developed awareness and expectations, chemically synthesized SAAs are expected to retain beneficial properties of their natural counterparts, such as biocompatibility and biodegradability, as well as endogenous-like hydrophilicity or hydrophobicity. Typical examples include glucose derivatives (H-GlcAPC-OH), which yield d-glucosamine-based β-SAAs, and Fmoc- or Boc-protected derivatives (Fmoc-GlcAPC-OH, Fmoc-GlcAPC(Bn)-OH, Boc-GlcAPC(Ac)-OH (Suhara et al. 1996, 2002, 2006; von Roedern et al. 1996)).
The most efficient and widely used method for the synthesis of oligopeptides and chimeras is solid-phase peptide synthesis (SPPS), which has recently been adopted for β-SAAs. (Goldschmidt Gőz et al. 2019, 2021; Nagy et al. 2019; Farkas et al. 2021; Duong et al. 2021) However, both the active ester formation and the coupling reaction conditions require the protection of the nucleophilic -OH groups, similar to the case of Ser and Thr residues. Acetylation is one of the simplest and easiest ways of providing -OH protection in carbohydrate chemistry and has already been used in solution phase peptide synthesis by Suhara et al. (2006). They obtained the N-Boc and O-acetyl protected sugar amino acid (β-SAA) from d-glucosamine‧HCl after completing a nine-step reaction sequence (Scheme 1). From the monomer, they synthesized new dimer, trimer and tetramer ‘carbopeptoids’ using conventional solution phase peptide synthesis (Suhara et al. 2006). Since our intention was to use the β-SAA moiety in SPPS, we needed to thoroughly investigate the stability of the -OAc-protected β-SAAs under the conditions of the peptide coupling and Fmoc deprotection steps, as well as when the crude product was removed from the resin.
Although a large number of coupling reagents and active esters have been used in the past (Valeur and Bradley 2009; El-Faham and Albericio 2011), HOBt/DIC (Hydroxybenzotriazole/N,N-Diisopropylcarbodiimide) are now the most widely used reagents (Albericio et al. 1998). The PyBOP/DIEA (Benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate/N,N-Diisopropylethylamine) reagent pair, which has been shown to minimize the risk of racemization, is also used to construct more challenging sequences. Recently, we have investigated and optimized different coupling reagents to generate GXXG model peptides (Goldschmidt Gőz et al. 2019; Nagy et al. 2019), where X was either a pyranoid (e.g. Fmoc-GlcAPU(Me)-OH) or a furanoid (e.g. Fmoc-RibAFU(ip)-OH) β-SAAs. To optimize both products formation and coupling as a function of time, their active ester formation was monitored by 1H NMR. For both furanoid and pyranoid β-SAAs, PyBOP/DIEA was found to be the best coupling reagent. Using this method, active esters are formed rapidly (within 20 min with high conversion: > 99%) and remain stable for at least 6–24 h, significantly longer than the duration of a typical coupling cycle (3 h).
Here, we demonstrate a shorter and scalable synthetic route for the preparation of the novel β-SAA coupling component Fmoc-GlcAPC-OH (1) and its per-O-acetylated derivative Fmoc-GlcAPC(Ac)-OH (2). Although O-acetyl protection is common in carbohydrate chemistry, and commonly used in the synthesis of glycopeptides and related compounds (Bermejo et al 2020), it is infrequently used in conventional SPPS. Therefore, in response to this synthetic challenge, we have fine-tuned protocols in which the reaction is monitored by NMR. Active ester formation and coupling with H-Gly-OMe was followed by time-resolved 1H NMR. Focusing on the different model peptides introduced earlier, both Ac-GXG-NH2 and Ac-GXXG-NH2 were prepared, where X represents the β-SAA. We show here, that the acetyl groups are highly stable under a variety of Fmoc and resin cleavage conditions, resulting in the fully protected oligopeptides. Furthermore, the O-acetyl groups can be subsequently removed by the standard Zemplén deacetylation method, widely used in carbohydrate chemistry, resulting in an unprotected and even more polar β-SAA-containing chimera.
Results and discussion
Synthesis of H-GlcAPC-OH derivatives
The synthesis of several H-GlcAPC-OH derivatives has already been described (Suhara et al. (loc cit; von Roeden et al. 1996), but the method published by Suhara et al. is the most widely accepted and used, leading to the N-Boc and O-Ac protected β-SAA: Boc-GlcAPC(Ac)-OH (3). However, we found that this route—which consists of 9 steps—is too long and that it could be shortened and optimized. Furthermore, we wanted to prepare building blocks suitable for SPPS (Goldschmidt Gőz et al. 2018; Nagy et al. 2017) and also for flow peptide chemistry (Farkas et al. 2021; Goldschmidt Gőz et al. 2021). Thus, in order to be compatible with Fmoc chemistry, the targeted β-SAA must be protected by Fmoc and Ac groups, respectively.
In the original Suhara synthesis, the key intermediate 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-d-glucopyranosyl-1-carbonitrile (5) was obtained in four steps and the final product 3 was obtained in five consecutive steps. The chain elongation leading to the nitrile derivative (5), made by OAc → Br → CN exchange, are the key steps of this synthesis. Subsequently, 5 was hydrolyzed in three steps to give the fully unprotected d-glucosamine-1-carboxylic acid (H-GlcAPC-OH, 8), which was then acetylated and N-protected by Boc to give Boc-GlcAPC(Ac)-OH (3), a molecule finally suitable for synthesis using solution-state protocols. This building block was used to complete the homooligomer synthesis with BOP/DIEA, a stepwise synthesis in solution, resulting in the dimer, trimer, etc. up to the hexamer (Suhara et al. 2006). The O-acetyl protection was removed after the final step using the Zemplén deacetylation method. Based on NMR and CD spectroscopy data, only the hexamer is long enough to adopt a 14-helix structure (Suhara et al. 2006). The -GlcAPC- building block can form oligomers by using different coupling agents (e.g. BOP/DIEA or HOBt/EDC‧HCl). However, the synthesis of the β-SAA building block is tedious in this way, and these synthons are only suitable for peptide synthesis in the solution state.
On the other hand, our fine-tuned procedure is based on N-Fmoc and O-Ac protected β-SAA suitable for SPPS. Starting from the commercially available 1,3,4,6-tetra-O-acetyl-2-deoxy-2-phthalimido-d-glucopyranose, Phth-GlcAPC(Ac)-Ac (10), chain elongation with TMSCN led directly to the nitrile derivative 5 (Scheme 2) (Myers and Lee 1984).The hydrolysis of the nitrile (5) gave the HCl salt of the unprotected H-GlcAPC-OH (8) in two steps: (a) Zemplén deacetylation removed the acetyl protection; (b) hydrolysis with 12% aqueous NaOH was carried out to partially remove the N-Phth protection and hydrolysis with 2 M HCl gave H-GlcAPC-OH (8). Then, this was converted to the Fmoc protected derivative, Fmoc-GlcAPC-OH (1). In the final step, the OH groups were conventionally acetylated (Ac2O in pyridine) to give the fully protected β-SAA, Fmoc-GlcAPC(Ac)-OH (2), which was shown (as detailed below) to be suitable for SPPS.
Our method is more efficient than that of Suhara et al. who obtain their final compound, Boc-GlcAPC(Ac)-OH, in 9 steps with an overall yield of 26%. We achieved our target molecules Fmoc-GlcAPC-OH (1) and obtained Fmoc-GlcAPC(Ac)-OH (2) in four and five steps, with overall yields of 36% and 29%, respectively. The process is also more environmentally friendly by reducing the number of synthetic steps. The key step, chain elongation, is performed in a single step. After their formation, both 1 and 2 can be precipitated with 2 M HCl. Molecules 5 and 2 were both successfully recrystallized from ethanol, eliminating column chromatography and providing a greener synthetic route.
Active ester formation
We have previously investigated several coupling reagents and conditions to obtain the best method for β-SAAs coupling (Nagy et al. 2019). Before proceeding with SPPS, we performed 1H NMR measurements to determine if the PyBOP/DIEA coupling reagent pair was suitable and to determine the optimal coupling conditions. We monitored the active ester formation of the β-SAAs (Fmoc-GlcAPC-OH and Fmoc-GlcAPC(Ac)-OH) as a function of time (Goldschmidt Gőz et al. 2019; Nagy et al. 2019). In DMF (Fig. 1a), the hydroxybenztriazol moiety of PyBOP transforms into the active ester moiety of both Fmoc-GlcAPC-OBt (11) and Fmoc-GlcAPC(Ac)-OBt (12), whose formation was indicated by the characteristic chemical shift changes of the aromatic HD with respect to the parent HD’ (Fig. 1b). The formation of the active ester was monitored for both β-SAA derivatives and we found that the formation of Fmoc-GlcAPC-OBt (11) requires ~ 1 h, resulting in an almost quantitative (96%) conversion (Fig. 1c and SFigure 1). We have also found that the active ester remains stable in solution for up to 24 h at room temperature. The reaction with Fmoc-GlcAPC(Ac)-OH (2) was slower (~ 3 h), but again the conversion was almost quantitative (~ 99%) and the product was stable even after 24 h. Note how useful the NMR monitoring of the reaction is for these β-SAAs, we were able to determine that the activation is slower than expected (1–3 h), but in return the active ester formations are almost quantitative.
Coupling with the active esters
The coupling of the two active β-SAAs esters, Fmoc-GlcAPC-OBt (11) and Fmoc-GlcAPC(Ac)-OBt (12), was investigated with glycine, the simplest and most flexible proteinogenic amino acid residue. The C-terminal of Gly was protected as a methyl ester: H-Gly-OMe. Slow amide bond formation was observed for both Fmoc-GlcAPC-OBt (11) and Fmoc-GlcAPC(Ac)-OBt (12) in the presence of 2 equivalents of H-Gly-OMe and 6 equivalents of DIEA: even after 24 h the conversion was only 63% and 17%, respectively. (Fig. 2 and SFigure 2). Although this pilot reaction was too slow and the conversion was insufficient for direct implementation for SPPS, it should also be remembered that these initial experiments were carried out in an NMR tube without any stirring. In the following, we will show that the same coupling reaction proceeds more rapidly and more effectively when the reaction conditions are optimized for SPPS.
Stability of the acetyl groups in chimera containing the -GlcAPC(Ac)- subunit
As our intention was to develop Fmoc chemistry suitable β-SAAs using acetylated derivatives, e.g. Fmoc-GlcAPC(Ac)-Gly-OMe, the question arises to what extent an acetyl protecting group resists cleavage conditions. Therefore, we investigated the stability of this group under conventional Fmoc cleavage conditions and beyond. The N-phthaloyl-protected model compound Phth-GlcAPC(Ac)-NH2 (13) was used, as the Phth-group is an inexpensive and simple amide protecting group (Fig. 3). Acetyl groups were found to be stable under conventionally accepted Fmoc cleavage conditions at room temperature (rt), such as 20% piperidine in DMF, or its equivalent 2% piperidine with 2% DBU in DMF (Fig. 3c–d and SFigure 3–5). Furthermore, even under the harshest conditions of flow chemistry (Farkas et al. 2021), 40% piperidine in DMF, the O-Ac group remains intact at 25 °C. In conclusion, acetyl groups seem to be suitable to protect -OH groups of β-SAAs moieties in SPPS, at least if (i) the chimera synthesis is not too long, (ii) the sequence is not too long and (iii) the sugar amino acid is not too close to the C-terminus of the sequence.
Coupling on solid phase
Our end products (1, 2) are promising candidates for coupling to SPPS. Having both the O-acetylated Fmoc-GlcAPC(Ac)-OH (2) and its “free” derivative Fmoc-GlcAPC-OH (1) in hand, SPPS was investigated for both. Note that the free β-SAA 1 has a total of 3 free -OH groups as nucleophiles, which could cause miscoupling, especially that of the primer -OH of the C-6 position. Armed with the previously established NMR data on active ester formation and coupling data, SPPS was used to generate the Ac-GXXG-NH2 model chimera (X = β-SAA: -GlcAPC- and -GlcAPC(Ac)-). Using this model peptide, we investigated all 3 different conditions of amide bond formation, namely those of α-β, β-β and β-α amide formation. For Fmoc-Gly-OH coupling, DIC/HOBt was used (1 h coupling time), whereas for β-SAAs PyBOP/DIEA was used (3 h). For Fmoc cleavage, 2% piperidine and 2% DBU in DMF protocol was used. When using Fmoc-GlcAPC-OH, a building block with free -OH groups, we found low coupling efficiencies (5–25% in Table 1). Furthermore, raw material analysis showed that the desired model compound was not obtained due to the large number of free -OH groups, e.g. MS data (see SFigure 11 and 16).
On the other hand, the per-O-acetylated Fmoc-GlcAPC(Ac)-OH was successfully incorporated into the Ac-GXXG-NH2 model chimera: both coupling efficiencies (84–91%) and yields (69–90%) are acceptable (Table 1). We have previously shown that all protecting groups used for Fmoc/tBu SPPS protocols can be successfully removed during the final cleavage step using an acid-reduced cleavage mixture containing 50% TFA (Goldschmidt Gőz et al. 2021; Duong et al. 2021). Using the same mixture in this case, we found that the crude model chimera Ac-GXXG-NH2 was isolated with all O-acetyl groups successfully retained. Furthermore, even when using the 95% TFA mixture, the O-acetyl protecting groups remain intact as confirmed by MS (SFigure 15). Thus, both the milder and the harsher TFA conditions allow to obtain the desired peracetylated chimera.
To further investigate the stability of the O-acetyl protecting groups, Ac-GXG-NH2 was synthesized and studied, as partial deacetylation is easy to detect on this simple chimera (SFigure 9). The final cleavage was carried out at 40 °C with 95% TFA and we found that the fully O-acetylated chimera is intact. Neither the MS spectrum nor the HPLC chromatogram show any sign of decomposition (SFigure 10 and 14).
To obtain the fully unprotected chimera, the Zemplén deacetylation method, a reaction widely used in carbohydrate chemistry to remove acetyl protection, was performed on Ac-GXG-NH2. As the deacetylation was performed in MeOH, which induces the collapse of the S RAM Tentagel® resin, the reaction was performed after the final cleavage. The purified per-O-acetyl Ac-GXG-NH2 was dissolved in MeOH and a few drops of 2 M NaOMe/MeOH solution were added. After 1 h at room temperature, the reaction was stopped by adding TFA to the mixture. The result was a fully -OH deprotected Ac-GXG-NH2 chimeric peptide (SFigure 13 and 17). In summary, the O-acetyl groups were successfully removed by the Zemplén deacetylation method, whereas the conventional 50% or 95% TFA final cleavage mixture did not interfere with the O-acetyl groups.
In the present work, new β-sugar amino acids, namely Fmoc-GlcAPC-OH (1) and Fmoc-GlcAPC(Ac)-OH (2), suitable for SPPS were synthesized in only four and five synthetic steps. Using NMR measurements, we found that the corresponding active esters are formed with PyBOP/DIEA in 1–3 h and when coupled with an α-amino acid, H-Gly-OMe, they form a β-α-amide bond. The stability of the O-acetyl protecting groups was confirmed by 1H NMR under Fmoc cleavage conditions using Phth-GlcAPC(Ac)-NH2 (13) as a model. Both Ac-GXG-NH2 and Ac-GXXG-NH2 chimeras with O-acetyl protected β-SAA (2) were successfully synthesized in SPPS: both coupling efficiencies and overall yields were found to be sufficient. The acetyl groups were removed by the Zemplén deacetylation method after final resin cleavage. In conclusion, it is possible to prepare chimeric peptides containing β-α-, α-β- and/or β-β-amide linkages using the new and efficiently synthesized β-SAA, Fmoc-GlcAPC(Ac)-OH (2). In addition, this biocompatible synthetic product is even more versatile and tunable, because the O-Ac groups of the β-SAA can be retained or removed at the end of the synthesis.
Analytical data for all compounds (HPLC chromatograms, NMR and MS spectra) can be found in Supporting information, in the online version.
Reagents, materials and solvents were purchased from Sigma-Aldrich, Merck, Reanal, VWR and Iris Biotech. Moisture-sensitive solvents were dried on molecular sieve (3 Å), while acetonitrile was distilled from CaH2. Solvents and reagents for MS measurements were purchased from VWR. TLC was performed on silica gel 60 F254, 230 mesh (E. Merck) and spots were detected by UV light (254 nm), charring with 5% H2SO4 solution.
Chimera peptides were measured by RP-HPLC on Aeris™ 3.6 μm peptide XB-C18 100 Å, LC Column 250 × 4.6 mm with eluents 0.1% TFA in H2O (A) and 0.08% TFA, 95% ACN/5% H2O (B), flow rate 0.9 ml/min and UV detection at 220 and 280 nm. Gradient was as follow: 0 min: 5% B, 30 min: 95% B, 33 min: 95% B, 33.1 min: 5% B, 45 min: 5% B.
NMR experiments were performed at 298 K on Bruker Avance DRX 500 MHz spectrometer equipped with TXI probe with z-gradient, operating at 500.13 MHz for 1H and 125.76 MHz for 13C. The sample concentrations ranged from 0.1 M to 0.2 M. Spectra were recorded in DMF-d7 using the solvent residual peak as the 1H internal reference. Spectra evaluation was done with TopSpin 4.1.1 software.
The mass spectrometry measurements were performed using a Bruker Amazon SL ion trap mass spectrometer equipped with an electrospray ion source.
3,4,6-Tri-O-acetyl-2-deoxy-2-phthalimido-β-d-glucopyranosyl-1-carboxamide (Phth-GlcAPC(Ac)-CN, 5) Tetra-O-acetyl-2-deoxy-2-phthalimido-d-glucopyranose (3.68 g, 7.7 mmol, 10) was dissolved in anhydrous acetonitrile (25 ml). Then, TMSCN (1.5 ml, 1.5 equiv) and BF3‧OEt2 (1.5 ml, 1.6 equiv) were added to this solution. The reaction mixture was stirred at room temperature overnight. After TLC (toluene:EtOAc 3:2) indicated the completion of the reaction, water (10 ml) was added to the reaction mixture, followed by 30 min of stirring. The solution was concentrated in vacuo. Then, CHCl3 (40 ml) was added to the residue orange oil, and the solution was washed three times with water. The organic phase was dried (MgSO4), filtered and concentrated in vacuo. The remaining crude product was crystallized from EtOH, twice. Yield: 1.55 g (40%). TLC (toluene:EtOAc, 3:2 v/v): Rf = 0.51; [α]D22 = + 65.3 (c = 1.06, CHCl3), lit. (Myers 1984) [α]D22 = 68.8 (c = 1.03, CHCl3)1H NMR (250 MHz, CDCl3) δ 7.89–7.74 (m, 4H, Phth-H), 5.72 (t, 3JH.H = 9.73 Hz, 1H, H-3), 5.35 (d, 3JH.H = 10.83 Hz, 1H, H-1), 5.17 (t, 3JH.H = 9.66 Hz, 1H, H-4), 4.64 (t, 3JH.H = 10.58 Hz, 1H, H-2), 4.31–4.13 (m, 2H, H-6), 3.89–3.83 (m, 1H, H-5).
2-Deoxy-2-(9-fluorenylmethoxycarbonylamino)-β-d-glucopyranosyl-1-carboxylic acid (Fmoc-GlcAPC-OH, 1) Phth-GlcAPC(Ac)-CN (5, 1 g, 2.25 mmol) was suspended in 12 m/m% NaOH solution (40 ml) and refluxed at 18 h. Then, cc HCl was added into the solution to get 2 M HCl concentration, and it was continued boiling at 18 h. After TLC (MeOH:AcOH 6:1) showed completion of the reaction, the mixture was left to cool to room temperature and filtered. The remaining solution was extracted with EtOAc (three times). Then, the water phase was concentrated in vacuo to remove HCl gas, and the remaining solution was lyophilized. Then, the dried product was dissolved in water/methanol (2/1, 15 ml). The pH of the solution was set to pH 8 with saturated aqueous NaHCO3 solution. Then, a solution of Fmoc-OSu (1.8 g, 1.1 equiv) in THF (15 ml) was added, and the pH was again set to pH 8 with NaHCO3 solution. The reaction mixture was stirred at room temperature for 2 days. After the reaction was completed, it was concentrated in vacuo to remove organic solvents. The remaining aqueous solution was diluted to 15 ml with water, pH set to pH 8 and extracted with EtOAc (5 times). The pH of the aqueous phase was set to 2 and it was cooled to 0 °C. The precipitate was filtered and dried. Yield: 0.85 g (88%). TLC (EtOAc:AcOH:H2O, 8:2:1 v/v/v): Rf = 0.34; [α]D22 = + 19.8 (c = 0.05, DMF), 1H NMR (500 MHz, CDCl3) δ 7.99 (d, 3JH,H = 6.4 Hz, 2H, Fmoc-HD); 7.88 (t, 3JH,H = 8.5 Hz, 2H, Fmoc-HA); 7.44 (td, 3JH,H = 14.8 and 2.2 Hz, 2H, Fmoc-HC); 7.30 (td, 3JH,H = 7.3 and 2.2 Hz, 2H, Fmoc-HB); 4.21 (dd, 3JH,H = 16.2 and 2.7 Hz, 1H, Fmoc CH1); 4.21 (t, 3JH,H = 14.5 Hz, 1H, Fmoc CH2A); 4.15 (dd, 3JH,H = 16.7 and 2.7 Hz, 1H, Fmoc CH2B); 3.95 (d, 3JH,H = 10.2 Hz, 1H, H-1); 3.82 (m, 1H, H-6A,B); 3.72 (overlapped td, 3JH,H = 10.2 and 4.3 Hz, 1H, H-2); 3.56 (m, 1H, H-5); 3.36 (dd, 3JH,H = 4.5 and 3.2 Hz, 1H, H-4); 3.28 (dd, 3JH,H = 4.8 and 8.6 Hz, 1H, H-3) 13C NMR (125 MHz, CDCl3) δ 170.7 (COOH); 156.3 (NHC(O)); 144.4 (Fmoc Ar2-C1); 144.2 (Fmoc Ar1-C1); 141.2 (Fmoc Ar2-C6); 141.1 (Fmoc Ar1-C6); 128.07 (Fmoc Ar1-C4); 128.04 (Fmoc Ar2-C4); 127.6 (Fmoc Ar2-C3); 127.5 (Fmoc Ar1-C3); 125.9 (Fmoc Ar1-C2); 125.7 (Fmoc Ar2-C2); 120.54 (Fmoc Ar1-C5); 120.5 (Fmoc Ar2-C5); 81.5 (C1); 78.3 (C5); 75.1 (C3); 70.9 (C4); 66.03 (Fmoc CH2); 61.5 (C6); 55.3 (C2); 47.1 (Fmoc C(2Ar)).
3,4,6-Tri-O-acetyl-2-deoxy-2-(9-fluorenylmethoxycarbonylamino)-β-d-glucopyranosyl-1-carboxylic acid (Fmoc-GlcAPC(Ac)-OH, 2) Fmoc-GlcAPC-OH (1, 1 g, 1.86 mmol) was suspended in pyridine (5 ml) and cooled to 0 °C, then, Ac2O (3 ml) was slowly added to this solution, and it was left to warm to room temperature, and stirred overnight. After TLC (EtOAc:MeOH 4:1) shows completion of the reaction, the reaction mixture was poured to ice-water (25 ml). The product was precipitated and filtered. The crude product was recrystallized from EtOH. Yield: 1.1 g (85%). TLC (MeOH:EtOAc:AcOH, 9:1:0.1 v/v/v): Rf = 0.31; [α]D22 = + 193.5 (c = 0.047, DMF), 1H NMR (500 MHz, CDCl3) δ 7.89 (d, 3JH,H = 7.6 Hz, 2H, Fmoc-HD); 7.64 (dd, 3JH,H = 11.1 and 7.8 Hz, 2H, Fmoc-HA); 7.41 (t, 3JH,H = 6.8 Hz, 2H, Fmoc-HC); 7.31 (t, 3JH,H = 7.1 Hz, 2H, Fmoc-HB); 5.37 (t, 3JH,H = 10.4 Hz, 1H, Fmoc CH2A); 4.98 (t, 3JH,H = 9.6 Hz, 1H, Fmoc CH2B); 4.35 (d, 3JH,H = 11.3 Hz, 1H, H-1); 4.23 (overlapped m, 1H, Fmoc CH1); 4.21 (m, 1H, H-6A); 4.19 (m, 1H, H-6B); 4.16 (m, 1H, H-5); 4.11 (dd, 3JH,H = 10.3 and 1.2 Hz, 1H, H-3); 3.98 (dd, 3JH,H = 10.3 and 10.1 Hz, 1H, H-2); 3.93 (m, 1H, H-5); 2.0 and 1.9 (s, 9H, Ac-CH3) 13C NMR (125 MHz, CDCl3) δ 170.2 (COOH); 169.9, 169.6, 169.2 (Ac-C(O)) 156.1 (NHC(O)); 144.4 (Fmoc Ar2-C1); 144.0 (Fmoc Ar1-C1); 141.2 (Fmoc Ar2-C6); 141.1 (Fmoc Ar1-C6); 127.7 (Fmoc Ar1-C4); 127.7 (Fmoc Ar2-C4); 127.2 (Fmoc Ar1,2-C3); 125.5 (Fmoc Ar1-C2); 125.4 (Fmoc Ar2-C2); 120.1 (Fmoc Ar1,2-C5); 77.4 (C1); 75.5 (C5); 73.7 (C3); 68.9 (C4); 66.5 (Fmoc CH2); 62.4 (C6); 53.6 (C2); 47.0 (Fmoc C(2Ar)).
For the SPPS S RAM Tentagel® resin was used (nominal capacity 0.24 mmol/g). Resin was swollen in DCM. The first step was the removal of the Fmoc group with common method (2% piperidine and 2% DBU in DMF, 3 + 17 min). The successful cleavage was analyzed by the Kaiser test. After that, the coupling of αAAs to resin was made by reagent pairs HOBt/DIC (αAA:HOBt:DIC 1:1:1) in DMF for 1 h, while that of βSAA either Fmoc-GlcAPC-OH (1) or Fmoc-GlcAPC(Ac)-OH (2) was accomplished by PyBOP/DIEA (βSAA:PyBOP:DIEA 1:1:2) in DMF for 3 h. Finally, resin was acetylated with Ac2O:DIEA:DMF (v/v/v, 1:1.2:3) for 45 min. Resin was washed with 3 × DMF, 3 × DCM, 1 × Et2O and dried in vacuo after finishing coupling and acetylation. During synthesis, the Fmoc group was removed with 2% piperidine and 2% DBU in DMF (3 + 17 min) and indicated by Kaiser test. The capacity of the resin was determined by UV–Vis measurement regarding to Fmoc chromophore amount (Fmoc-piperidine adduct) released by using 50% piperidine in DMF (Chan and White 2000). The final cleavage from S RAM Tentagel® resin was carried out with 50% TFA, 45% DCM, 2.5% TIS and 2.5% H2O mixture, or 95% TFA, 2.5% TIS and 2.5% H2O mixture (5–10 mL/g resin) for 3 h. Resin was washed with 2 × DMF, 3 × DCM and 2 × MeOH and solvent was removed in vacuo. The crude products were precipitated with diethyl ether.
The purified Ac-Gly-GlcAPC(Ac)-Gly-NH2 (20 mg) was dissolved in MeOH (2 ml) and 2 M NaOMe/MeOH (1 ml) solution was added. After 1 h at room temperature, the reaction was stopped with the addition of TFA (1 ml). The acidic solution was concentrated to get white solids (10 mg).
Analytical data of chimera peptides
Rp-HPLC: 11.82 min, MS (ESI, m/z): [M + H]+ calcd. For 489.18; found: 489.15.
Rp-HPLC: 16.01 min, MS (ESI, m/z): [M + H]+ calcd. for 804.27; found: 804.21.
Rp-HPLC: 3.61 min, MS (ESI, m/z): [M + H]+ calcd. for 363.05; found: 363.06.
3,4,6-Tri-O-acetyl-2-deoxy-2-(9-fluorenylmethoxycarbonylamino)-β-d-glucopyranosyl-1-carboxylic acid HOBt ester
2-Deoxy-2-(9-fluorenylmethoxycarbonylamino)-β-d-glucopyranosyl-1-carboxylic acid HOBt ester
Fmoc protected β-sugar amino acid HOBt ester
Glycine methyl ester
- Phth-GlcAPC(Ac)-NH2 :
Solid-phase peptide synthesis
β-Sugar amino acid
Albericio F, Bofill JM, El-Faham A, Kates SA (1998) Use of onium salt-based coupling reagents in peptide synthesis. J Org Chem 63:9678–9683
BeMiller JN (2008). In: Thiem J (ed) Glycoscience: chemistry and chemical biology. Springer, Berlin
Bermejo IA, Navo CD, Castro-López J, Guerreiro A, Jiménez-Moreno E, Sánchez Fernández EM, García-Martín F, Hinou H, Nichimura S-I, García Fernández JM, Ortiz Mellet C, Avenoza A, Busto JH, Bernardes GJL, Hurtado-Guerrero R, Peregrina JM, Corzana F (2020) Synthesis, conformational analysis and in vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment. Chem Sci 11:3996–4006
Chan WC, White PD (2000) Fmoc solid phase peptide synthesis: a practical approach. Oxford University Press, Oxford
Chandrasekhar S, Reddy SM, Jagadeesh B, Prabhakar A, Ramana Rao MHV, Jagannadh B (2004) Formation of a stable 14-helix in short oligomers of furanoid cis-β-sugar-amino acid. J Am Chem Soc 126:13586–13587
Duong KHY, Goldschmidt Gőz V, Pintér I, Perczel A (2021) Synthesis of chimera oligopeptide including furanoid ß-sugar amino acid derivatives with free OHs: mild but successful removal of the 1,2-O-isopropylidene from the building block. Amino Acids 53:281–294
El Oualid F, van der Marel GA, Overkleeft HS, Overhand M (2004) Alkylated sugar amino acids: a new entry toward highly functionalized dipeptide isosters. Org Lett 6:3167–3170
El-Faham A, Albericio F (2011) Peptide coupling reagents, more than a letter soup. Chem Rev 111:6557–6602
Farkas V, Ferentzi K, Horváti K, Perczel A (2021) Cost effective flow peptide synthesis: Metamorphosis of HPLC. Org Process Res Dev 25:182–191
Gellman SH (1998) Foldamers: a manifesto. Acc Chem Rev 31:173–180
Gervay-Hague J, Weathers JTM (2002) Pyranosyl sugar amino acid conjugates: their biological origins, synthetic preparations, and structural characterization. J Carbohydr Chem 21:867–910
Goldschmidt Gőz V, Pintér I, Harmat V, Perczel A (2018) Approaches to pyranuronic β-sugar amino acid building blocks of peptidosaccharide foldamer. Eur J Org Chem 3:355–361
Goldschmidt Gőz V, Nagy A, Farkas V, Keszei E, Perczel A (2019) Unwanted hydrolysis or α/β-peptide bond formation: how long should the rate-limiting coupling step take? RSC Adv 9:30720–30728
Goldschmidt Gőz V, Duong KHY, Horváth D, Ferentzi K, Farkas V, Perczel A (2021) Application of Sugar amino acids: flow chemistry used for α/β-chimera synthesis. Eur J Org Chem 2021:6071–6083
Gruner SAW, Locardi E, Lohof E, Kessler H (2002a) Carbohydrate-based mimetics in drug design: sugar amino acids and carbohydrate scaffolds. Chem Rev 102:491–514
Gruner SAW, Truffault V, Voll G, Locardi E, Stöckle M, Kessler H (2002b) Design, synthesis, and NMR structure of linear and cyclic oligomers containing novel furanoid sugar amino acids. Chem Eur J 8:4365–4376
Lohof E, Burkhart F, Born MA, Planker E, Kessler H (1999) Advances in amino acid mimetics and peptidomimetics. JAI Press Inc., Stanford
Lohof E, Planker E, Mang C, Burkhart F, Dechantsreiter MA, Haubner R, Wester H-J, Schwaiger M, Hölzemann G, Goodman SL, Kessler H (2000) Carbohydrate derivatives for use in drug design: cyclic αv-selective RGD peptides. Angew Chem Int Ed Engl 39:2761–2764
Mayes HB, Broadbelt LJ, Beckham GT (2014) How sugars pucker: electronic structure calculations map the kinetic landscape of five biologically paramount monosaccharides and their implications for enzymatic catalysis. JACS 136:1008–1022
McDevitt JP, Lansbury PT (1996) Glycosamino acids: new building blocks for combinatorial synthesis. J Am Chem Soc 118:3818–3828
Menyhárd DK, Hudáky I, Jákli I, Gy J, Perczel A (2017) Predictable conformational diversity in foldamers of sugar amino acids. J Chem Inf Model 57:757–768
Myers RW, Lee YC (1984) Synthesis and characterization of some anomeric pairs of per-O-acetylated aldohexopyranosyl cyanides (per-O-acetylated 2,6-anhydroheptononitriles). On the reaction of per-O-acetylaldohexopyranosyl bromides with mercuric cyanide in nitromethane. Carbohydr Res 132:61–82
Nagy A, Csordás B, Zsoldos-Mády V, Pintér I, Farkas V, Perczel A (2017) C-3 epimers of sugar amino acids as foldameric building blocks: improved synthesis, useful derivatives, coupling strategies. Amino Acids 49:223–240
Nagy A, Goldschmidt Gőz V, Pintér I, Farkas V, Perczel A (2019) α/β-Chimera peptide synthesis with cyclic β-sugar amino acids: the efficient coupling protocol. Amino Acids 51:669–678
Pigman W, Horton D (1972) The Carbohydrates: Chemistry and Biochemistry, vol 1. Academic Press, Cambridge
Rao VSR (1998) Conformation of carbohydrates. CRC Press, London
Risseeuw MDP, Overhand M, Fleet GWJ, Simone MI (2013) A compendium of cyclic sugar amino acids and their carbocyclic and heterocyclic nitrogen analogues. Amino Acids 45:613–689
Robty JF (1998) Essentials of carbohydrate chemistry. Springer, New York
Roseman SJ (2001) Reflections on glycobiology. J Biol Chem 276:41527–41542
Seeberger PH (2005) Exploring life’s sweet pot. Nature 437:1239
Stern R, Jedrzejas M (2008) Carbohydrate polymers at the center of life’s origins: the importance of molecular processivity. Chem Rev 108:5061–5085
Suhara Y, Hildreth JEK, Ichikawa Y (1996) Synthesis of a new carbohydrate mimetics: “Carbopeptoid” containing a C-1 carboxylate and C-2 amino group. Tetrahedron Lett 37:1575–1578
Suhara Y, Yamaguchi Y, Collins B, Schnaar RL, Yanagishita M, Hildreth JEK, Shimada I, Ichikawa Y (2002) Oligomers of glycamino acid. Bioorg Med Chem 10:1999–2013
Suhara Y, Kurihara M, Kittaka A, Ichikawa Y (2006) Efficient synthesis of carbopeptoid oligomers: insight into mimicry of β-peptide. Tetrahedron 62:8207–8217
Tian G-Z, Wang X-L, Hu J, Wang X-B, Guo X-Q, Yin J (2015) Recent progress of sugar a, omo acids: synthetic strategies and applications as glycomimetics and peptidomimetics. Chin Chem Lett 26:922–930
Valeur E, Bradley M (2009) Amide bond formation: beyond the myth of coupling reagents. Chem Soc Rev 38:606–631
Varki A (2022) Essentials of glycobiology, 4th edn. Cold Spring Harbor Laboratory Press, New York
von Roedern EG, Lohof E, Hessler G, Hoffmann M, Kessler H (1996) Synthesis and Conformational analysis of linear and cyclic peptides containing sugar. Amino Acids 118:10156–10167
Xiao R, Dane EL, Zeng J, McKnight CJ, Grinstaff MW (2017) Synthesis of altrose poly-amido-saccharides with β-N-(1→2)-d-amide linkages: a right-handed helical conformation engineered in at the monomer level. JACS 139:14217–14223
This work was supported by scholarships provided by Beregi Fellowship sponsored by Servier Research Institute and the Foundation for the Hungarian Peptide and Protein Research. This work was completed in the ELTE Thematic Excellence Program supported by the Hungarian Ministry for Innovation and Technology project no. TKP2020-NKA-06 (SzintPlus). Project no. 2018-1.2.1-NKP-2018-00005 has been implemented with the support provided from the National Research, Development, and Innovation Fund of Hungary, financed under the 2018-1.2-1-NKP funding scheme (HunProtExc). Project number RRF-2.3.1-21-2022-00015 is implemented with the support of the European Union’s Recovery and Resilience Instrument (PharmaLab).
Open access funding provided by Eötvös Loránd University.
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Handling editor: F. Albericio.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Varga, I., Goldschmidt Gőz, V., Pintér, I. et al. Acetyl group for proper protection of β-sugar-amino acids used in SPPS. Amino Acids 55, 969–979 (2023). https://doi.org/10.1007/s00726-023-03278-1